A composite scoring of genotypes discriminates coronary heart disease risk beyond conventional risk factors in the Boston Puerto Rican Health Study

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 20, Issue 3, 2010, Pages 157-164

  Junyent, M ^a   Tucker, K L ^a   Shen, J ^a   Lee, Y C ^a   Smith, C E ^a   Mattei, J ^a   Lai, C Q ^a   Parnell, L D ^a   Ordovas, J M ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Conventional risk factors; Coronary heart disease; Genes; Genetic predisposition score; Single nucleotide polymorphism

Indexed keywords

AGED; ARTICLE; CORONARY ARTERY DISEASE; DRINKING BEHAVIOR; ETHNOLOGY; EXERCISE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HISPANIC; HOMOZYGOTE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; MIDDLE AGED; PUERTO RICO; RISK; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; UNITED STATES;

AGED; ALCOHOL DRINKING; BOSTON; CORONARY DISEASE; EXERCISE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HISPANIC AMERICANS; HOMOZYGOTE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUERTO RICO; RISK FACTORS; SMOKING;

EID: 77549087690     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.03.016     Document Type: Article

References (30)

1. Rosamond W., Flegal K., Furie K., Go A., Greenlund K., Haase N., et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117 (2008) e25-e146
2. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
3. Junyent M., Zambón D., Gilabert R., Núñez I., Cofán M., and Ros E. Carotid atherosclerosis and vascular age in the assessment of coronary heart disease risk beyond the Framingham Risk Score. Atherosclerosis 196 (2008) 803-809
4. Vaidya D., Yanek L.R., Moy T.F., Pearson T.A., Becker L.C., and Becker D.M. Incidence of coronary artery disease in siblings of patients with premature coronary artery disease: 10 years of follow-up. Am J Cardiol 100 (2007) 1410-1415
5. Samani N.J., Erdmann J., Hall A.S., Hengstenberg C., Mangino M., Mayer B., et al. WTCCC and the Cardiogenics Consortium. Genomewide association analysis of coronary artery disease. N Engl J Med 357 (2007) 443-453
6. Yamada Y., Izawa H., Ichihara S., Takatsu F., Ishihara H., Hirayama H., et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 347 (2002) 1916-1923
7. Humphries S.E., Cooper J.A., Talmud P.A., and Miller G.J. Candidate gene genotypes, along with conventional risk factor assessment, improve estimation of coronary heart disease risk in healthy UK men. Clin Chem 53 (2007) 8-16
8. Morgan T.M., Xiao L., Lyons P., Kassebaum B., Krumholz H.M., and Spertus J.A. Investigation of 89 candidate gene variants for effects on all-cause mortality following acute coronary syndrome. BMC Med Genet 9 (2008) 66-74
9. Humphries S.E. Cardiovascular disease risk prediction using genetic information (gene-scores): is it really informative?. Curr Opin Lipidol 19 (2008) 128-132
10. Yiannakouris N., Trichopoulou A., Benetou V., Psaltopoulou T., Ordovas J.M., and Trichopoulos D. A direct assessment of genetic contribution to the incidence of coronary infarct in the general population Greek EPIC cohort. Eur J Epidemiol 21 (2006) 859-867
11. Trichopoulou A., Yiannakouris N., Bamia C., Benetou V., Trichopoulos D., and Ordovas J.M. Genetic predisposition, nongenetic risk factors, and coronary infarct. Arch Intern Med 168 (2008) 891-896
12. Morrison A.C., Bare L.A., Chambless L.E., Ellis S.G., Mallon M., Kane J.P., et al. Prediction of coronary heart disease risk using a genetic risk score: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 166 (2007) 28-35
13. Kathiresan S., Melander O., Anevski D., Guiducci C., Burtt N.P., Roos C., et al. Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med 358 (2008) 1240-1249
14. Junyent M., Tucker K.L., Smith C.E., Garcia-Rios A., Mattei J., Lai C.Q., et al. The effects of ABCG5/G8 polymorphisms on plasma HDL cholesterol concentrations depend on smoking habit in the Boston Puerto Rican health study. J Lipid Res 50 (2009) 565-573
15. Lee I.M., and Paffenbarger Jr. R.S. Physical activity and stroke incidence: the Harvard Alumni Health Study. Stroke 29 (1998) 2049-2054
16. Greenland P., Smith Jr. S.C., and Grundy S.M. Improving coronary heart disease risk assessment in asymptomatic people. The role of traditional risk factors and non-invasive cardiovascular tests. Circulation 104 (2001) 1863-1867
17. Livak K.J. Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet Anal 14 (1999) 143-149
18. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection. Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final report. Circulation 106 (2002) 3143-3152
19. Drenos F., Whittaker J.C., and Humphries S.E. The use of meta-analysis risk estimates for candidate genes in combination to predict coronary heart disease risk. Ann Hum Genet 71 (2007) 611-619
20. Keavney B., Palmer A., Parish S., Clark S., Youngman L., Danesh J., et al., International Studies of Infarct Survival (ISIS) Collaborators. Lipid-related genes and myocardial infarction in 4685 cases and 3460 controls: discrepancies between genotype, blood lipid concentrations, and coronary disease risk. Int J Epidemiol 33 (2004) 1002-1013
21. Bentzen J., Poulsen P., Vaag A., and Fenger M. Further studies of the influence of apolipoprotein B alleles on glucose and lipid metabolism. Hum Biol 75 (2003) 687-703
22. Wilson P.W., Myers R.H., Larson M.G., Ordovas J.M., Wolf P.A., and Schaefer E.J. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA 272 (1994) 1666-1671
23. Russo G.T., Meigs J.B., Cupples L.A., Demissie S., Otvos J.D., Wilson P.W., et al. Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. Atherosclerosis 158 (2001) 173-181
24. van Bockxmeer F.M., Liu Q., Mamotte C., Burke V., and Taylor R. Lipoprotein lipase D9N, N291S and S447X polymorphisms: their influence on premature coronary heart disease and plasma lipids. Atherosclerosis 157 (2001) 123-129
25. Gagné S.E., Larson M.G., Pimstone S.N., Schaefer E.J., Kastelein J.J., Wilson P.W., et al. A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: the Framingham Offspring Study. Clin Genet 55 (1999) 450-454
26. Fish J.E., Matouk C.C., Yeboah E., Bevan S.C., Khan M., Patil K., et al. Hypoxia-inducible expression of a natural cis-antisense transcript inhibits endothelial nitric-oxide synthase. J Biol Chem 282 (2007) 15652-15666
27. Shen J., Arnett D.K., Pérez-Martínez P., Parnell L.D., Lai C.Q., Peacock J.M., et al. The effect of IL6-174C/G polymorphism on postprandial triglyceride metabolism in the GOLDN studyboxs. J Lipid Res 49 (2008) 1839-1845
28. Karvanen J., Silander K., Kee F., Tiret L., Salomaa V., Kuulasmaa K., et al. The impact of newly identified loci on coronary heart disease, stroke and total mortality in the MORGAM prospective cohorts. Genet Epidemiol 33 (2009) 237-246
29. Beswick A., and Brindle P. Risk scoring in the assessment of cardiovascular risk. Curr Opin Lipidol 14 (2006) 375-386
30. Zhang B., Menzin J., Friedman M., Korn J.R., and Burge R.T. Predicted coronary risk for adults with coronary heart disease and low HDL-C: an analysis from the US National Health and Nutrition Examination Survey. Curr Med Res Opin 24 (2008) 2711-2777